0925_THOR-HAMMR-fig-lg (IMAGE)

Rice University

0925_THOR-HAMMR-fig-lg

Caption

A figure illustrating how a “closed-loop” implant called HAMMR (short for “hybrid advanced molecular manufacturing regulator”) will be used to treat recurrent ovarian cancer. The implant, which is small enough to be implanted with minimally invasive surgery, is being developed by a Rice University-led team of researchers from eight universities and two companies in seven states. The Advanced Research Projects Agency for Health awarded $45 million to fast-track development of the implant, which includes funding for a first-phase clinical trial within five years.

Credit

Credit: Veiseh Lab/Rice University

Usage Restrictions

Must credit: Veiseh Lab/Rice University

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.